Lu 35-138 is a dual dopamine D4 receptor antagonist and serotonin reuptake inhibitor (SRI) among other actions which belongs to the tetrahydropyridinylindole group and was under development for the treatment of schizophrenia but was never marketed.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.